<p>The pharmacophore model generated from the binding modes of (A) C15 and (B) LTA4. The amino acid residues of the enzyme are shown in gray thin stick form whereas the bound C15 and LTA4 are shown in thick stick form. The secondary structure cartoon of the protein is colored based on the hydrophobicity of the amino acid residues. (C) Pharm-A (D) Pharm-B, the final hybrid pharmacophore models.</p
A deriving pharmacophore model from the three-dimensional structure of a target protein provides hel...
<p>Color coding of pharmacophoric features: green, hydrophobic site; magenta, acceptor site; cyan, d...
A pharmacophore describes the arrangement of molecular features a ligand must contain to efficacious...
<p>The key pharmacophoric features generated from the binding modes of (A) C1 and (B) Ang I. The ami...
<p>The metal ions and key residues of the representative Shh structure of (a) the Shh-PL2 (slashdot ...
A detection of the three-dimensional binding mode between a protein and a chemical compound is valua...
Pharmacophore modelling is a well-known structure based drug design method allowing fast virtual scr...
<p>Four active pulvinic acid derivatives (IDs: 11, 15, 36, 49 [<a href="http://www.plosone.org/artic...
<p>Generated pharmacophore models (A) Hypo A, (B) Hypo B and (C) Hypo C, in which hydrophobic, hydro...
<p>The red ball represents a “Hydrogen bond acceptor”, the blue ball represents a “Hydrogen bond don...
<p>(A) Three-dimensional representation of the interactions of reference ligand and receptor protein...
Pharmacophore modeling is a successful yet very diverse subfield of computer-aided drug design. The ...
<p>The development of an optimal combination of pharmacophore models. Transparent boxes show the log...
<p>Pharmacophore models (A) Hypo A, (B) Hypo B, and (C) Hypo C fitted to <b>22</b> and (D) overlay o...
A pharmacophore describes the framework of molecular features that are vital for the biological acti...
A deriving pharmacophore model from the three-dimensional structure of a target protein provides hel...
<p>Color coding of pharmacophoric features: green, hydrophobic site; magenta, acceptor site; cyan, d...
A pharmacophore describes the arrangement of molecular features a ligand must contain to efficacious...
<p>The key pharmacophoric features generated from the binding modes of (A) C1 and (B) Ang I. The ami...
<p>The metal ions and key residues of the representative Shh structure of (a) the Shh-PL2 (slashdot ...
A detection of the three-dimensional binding mode between a protein and a chemical compound is valua...
Pharmacophore modelling is a well-known structure based drug design method allowing fast virtual scr...
<p>Four active pulvinic acid derivatives (IDs: 11, 15, 36, 49 [<a href="http://www.plosone.org/artic...
<p>Generated pharmacophore models (A) Hypo A, (B) Hypo B and (C) Hypo C, in which hydrophobic, hydro...
<p>The red ball represents a “Hydrogen bond acceptor”, the blue ball represents a “Hydrogen bond don...
<p>(A) Three-dimensional representation of the interactions of reference ligand and receptor protein...
Pharmacophore modeling is a successful yet very diverse subfield of computer-aided drug design. The ...
<p>The development of an optimal combination of pharmacophore models. Transparent boxes show the log...
<p>Pharmacophore models (A) Hypo A, (B) Hypo B, and (C) Hypo C fitted to <b>22</b> and (D) overlay o...
A pharmacophore describes the framework of molecular features that are vital for the biological acti...
A deriving pharmacophore model from the three-dimensional structure of a target protein provides hel...
<p>Color coding of pharmacophoric features: green, hydrophobic site; magenta, acceptor site; cyan, d...
A pharmacophore describes the arrangement of molecular features a ligand must contain to efficacious...